Overview

Phase II Trial of Ontak With Metastatic Melanoma

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ONTAK is an effective treatment in patients with Stage IV Melanoma
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center
Collaborator:
University of Louisville
Treatments:
Denileukin diftitox